The fetal origins of the metabolic syndrome: Can we intervene?

Journal of Pregnancy

Volumn 2012, Issue , 2012, Pages

  Ma, Noelle ^a,b   Hardy, Daniel B ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b CHILDREN S HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIOXIDANT; ASCORBIC ACID; EXENDIN 4; FOLIC ACID; MELATONIN; OMEGA 3 FATTY ACID; PEPTIDE; RESVERATROL; STILBENE DERIVATIVE; TRACE ELEMENT; VENOM;

DIET SUPPLEMENTATION; DIET THERAPY; FEMALE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MATERNAL NUTRITION; METABOLIC SYNDROME X; METABOLISM; PREGNANCY; PRENATAL EXPOSURE; REVIEW;

ANTIOXIDANTS; ASCORBIC ACID; DIET THERAPY; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FEMALE; FETAL GROWTH RETARDATION; FOLIC ACID; HUMANS; HYPOGLYCEMIC AGENTS; MELATONIN; METABOLIC SYNDROME X; MICRONUTRIENTS; PEPTIDES; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PRENATAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; STILBENES; VENOMS;

EID: 84867320477     PISSN: 20902727     EISSN: 20902735     Source Type: Journal    
DOI: 10.1155/2012/482690     Document Type: Review

References (132)

1. Barker D. J. P., Hales C. N., Fall C. H. D., Osmond C., Phipps K., Clark P. M. S., Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993 36 1 62 67 2-s2.0-0027529974 10.1007/BF00399095 (Pubitemid 23018337)
2. Jaquet D., Gaboriau A., Czernichow P., Levy-Marchal C., Insulin resistance early in adulthood in subjects born with intrauterine growth retardation. The Journal of Clinical Endocrinology and Metabolism 2000 85 4 1401 1406 2-s2.0-0034456325 10.1210/jc.85.4.1401 (Pubitemid 32289480)
3. Nilsson P. M., Östergren P. O., Nyberg P., Söderström M., Allebeck P., Low birth weight is associated with elevated systolic blood pressure in adolescence: a prospective study of a birth cohort of 149,378 Swedish boys. Journal of Hypertension 1997 15 12 1627 1631 2-s2.0-0031446544 10.1097/00004872-199715120-00064 (Pubitemid 28029656)
4. Lopez A. D., Mathers C. D., Ezzati M., Jamison D. T., Murray C. J., Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. The Lancet 2006 367 9524 1747 1757 2-s2.0-33646799069 10.1016/S0140-6736(06)68770-9 (Pubitemid 43767064)
5. Ford E. S., Giles W. H., Mokdad A. H., Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 2004 27 10 2444 2449 2-s2.0-4644279733 10.2337/diacare.27.10.2444 (Pubitemid 39281399)
6. Lloyd-Jones D., Adams R. J., Brown T. M., Carnethon M., Dai S., De Simone G., Ferguson T. B., Ford E., Furie K., Gillespie C., Go A., Greenlund K., Haase N., Hailpern S., Ho P. M., Howard V., Kissela B., Kittner S., Lackland D., Lisabeth L., Marelli A., McDermott M. M., Meigs J., Mozaffarian D., Mussolino M., Nichol G., Roger V. L., Rosamond W., Sacco R., Sorlie P., Stafford R., Thom T., Wasserthiel-Smoller S., Wong N. D., Wylie-Rosett J., Executive summary: heart disease and stroke statistics-2010 update: a report from the american heart association. Circulation 2010 121 7 e46 e215 2-s2.0-77649126524 10.1161/CIRCULATIONAHA.109.192667
7. McGuire S., Shields M., Carroll M.D., Ogden C.L. adult obesity prevalence in Canada and the United States. NCHS data brief no. 56, Hyattsville, MD: national Center for Health Statistics, 2011. Advances in Nutrition 2011 2 4 368 369 2-s2.0-84861674298
8. Ogden C. L., Carroll M. D., Kit B. K., Flegal K. M., Prevalence of obesity and trends in body mass index among US children and adolescents, 19992010. JAMA 2012 307 5 483 490 2-s2.0-84856433589 10.1001/jama.2012.40
9. Law M. R., Wald N. J., Rudnicka A. R., Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 2003 326 7404 1423 1427 2-s2.0-0037490080 (Pubitemid 36776152)
10. LaRosa J. C., He J., Vupputuri S., Effect of statins on risk of coronary disease. A meta-analysis of randomized controlled trials. JAMA 1999 282 24 2340 2346 2-s2.0-0033596281 (Pubitemid 30013066)
11. Escobar C., Echarri R., Barrios V., Relative safety profiles of high dose statin regimens. Vascular Health and Risk Management 2008 4 3 525 533 2-s2.0-47849096593 (Pubitemid 352037914)
12. Langley S. C., Browne R. F., Jackson A. A., Altered glucose tolerance in rats exposed to maternal low protein diets in utero. Comparative Biochemistry and PhysiologyA Physiology 1994 109 2 223 229 2-s2.0-0028067645 10.1016/0300-9629(94)90124-4 (Pubitemid 24300359)
13. Dahri S., Snoeck A., Reusens-Billen B., Remacle C., Hoet J. J., Islet function in offspring of mothers on low-protein diet during gestation. Diabetes 1991 40 2 115 120 2-s2.0-0026316923
14. Lucas A., Baker B. A., Desai M., Hales C. N., Nutrition in pregnant or lactating rats programs lipid metabolism in the offspring. British Journal of Nutrition 1996 76 4 605 612 2-s2.0-0029806228 10.1079/BJN19960066 (Pubitemid 26372282)
15. Sohi G., Marchand K., Revesz A., Arany E., Hardy D. B., Maternal protein restriction elevates cholesterol in adult rat offspring due to repressive changes in histone modifications at the cholesterol 7 α -hydroxylase promoter. Molecular Endocrinology 2011 25 5 785 798 2-s2.0-79955764891 10.1210/me.2010-0395
16. Wang Z., Huang Z., Lu G., Lin L., Ferrari M., Hypoxia during pregnancy in rats leads to early morphological changes of atherosclerosis in adult offspring. American Journal of Physiology 2009 296 5 H1321 H1328 2-s2.0-66149115909 10.1152/ajpheart.00440.2008
17. Lewis R. M., James L. A., Zhang J., Byrne C. D., Hales C. N., Effects of maternal iron restriction in the rat on hypoxia-induced gene expression and fetal metabolite levels. British Journal of Nutrition 2001 85 2 193 201 2-s2.0-0035084634 (Pubitemid 32236806)
18. Woodall S. M., Johnston B. M., Breier B. H., Gluckman P. D., Chronic maternal undernutrition in the rat leads to delayed postnatal growth and elevated blood pressure of offspring. Pediatric Research 1996 40 3 438 443 2-s2.0-0029787229 (Pubitemid 26282578)
19. Benediktsson R., Lindsay R. S., Noble J., Seckl J. R., Edwards C. R. W., Glucocorticoid exposure in utero: new model for adult hypertension. The Lancet 1993 341 8841 339 341 2-s2.0-0027509970 10.1016/0140-6736(93)90138-7 (Pubitemid 23039701)
20. Reynolds R. M., Corticosteroid-mediated programming and the pathogenesis of obesity and diabetes. Journal of Steroid Biochemistry and Molecular Biology 2010 122 13 3 9 2-s2.0-77956479343 10.1016/j.jsbmb.2010.01.009
21. Machlin L. J., Bendich A., Free radical tissue damage: protective role of antioxidant nutrients. The FASEB Journal 1987 1 6 441 445 2-s2.0-0023464342
22. Slater T. F., Free-radical mechanisms in tissue injury. Biochemical Journal 1984 222 1 1 15 2-s2.0-0021763962
23. Bodannes R. S., Chan P. C., Ascorbic acid as a scavenger of singlet oxygen. FEBS Letters 1979 105 2 195 196 2-s2.0-0018666224 10.1016/0014-5793(79) 80609-2 (Pubitemid 10237600)
24. Frei B., England L., Ames B. N., Ascorbate is an outstanding antioxidant in human blood plasma. Proceedings of the National Academy of Sciences of the United States of America 1989 86 16 6377 6381 2-s2.0-0001218860 (Pubitemid 19210655)
25. Nishikimi M., Oxidation of ascorbic acid with superoxide anion generated by the xanthine xanthine oxidase system. Biochemical and Biophysical Research Communications 1975 63 2 463 468 2-s2.0-0016639130
26. McCay P. B., Vitamin E: interactions with free radicals and ascorbate. Annual Review of Nutrition 1985 5 323 340 2-s2.0-0021776272
27. Packer J. E., Slater T. F., Willson R. L., Direct observation of a free radical interaction between vitamin E and vitamin C. Nature 1979 278 5706 737 738 2-s2.0-0018348794 (Pubitemid 9160276)
28. Yung H. W., Calabrese S., Hynx D., Hemmings B. A., Cetin I., Charnock-Jones D. S., Burton G. J., Evidence of placental translation inhibition and endoplasmic reticulum stress in the etiology of human intrauterine growth restriction. American Journal of Pathology 2008 173 2 451 462 2-s2.0-48749124981 10.2353/ajpath.2008.071193
29. Gupta P., Narang M., Banerjee B. D., Basu S., Oxidative stress in term small for gestational age neonates born to undernourished mothers: a case control study. BMC Pediatrics 2004 4, article 14 2-s2.0-12944314771 10.1186/1471-2431-4-14 (Pubitemid 40177075)
30. Lee B. E., Hong Y. C., Lee K. H., Kim Y. J., Kim W. K., Chang N. S., Park E. A., Park H. S., Hann H. J., Influence of maternal serum levels of vitamins C and E during the second trimester on birth weight and length. European Journal of Clinical Nutrition 2004 58 10 1365 1371 2-s2.0-5744242301 10.1038/sj.ejcn.1601976 (Pubitemid 39377918)
31. Ornoy A., Avgil Tsadok M., Yaffe P., Zangen S. W., The Cohen diabetic rat as a model for fetal growth restriction: vitamins C and E reduce fetal oxidative stress but do not restore normal growth. Reproductive Toxicology 2009 28 4 521 529 2-s2.0-70350237067 10.1016/j.reprotox.2009.06.005
32. Chen Y. H., Xu D. X., Zhao L., Wang H., Wang J. P., Wei W., Ascorbic acid protects against lipopolysaccharide-induced intra-uterine fetal death and intra-uterine growth retardation in mice. Toxicology 2006 217 1 39 45 2-s2.0-28744437468 10.1016/j.tox.2005.08.010 (Pubitemid 41758391)
33. Poston L., Briley A., Seed P., Kelly F., Shennan A., Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. The Lancet 2006 367 9517 1145 1154 2-s2.0-33645988840 10.1016/S0140-6736(06)68433-X
34. Rumbold A. R., Crowther C. A., Haslam R. R., Dekker G. A., Robinson J. S., Vitamins C and E and the risks of preeclampsia and perinatal complications. The New England Journal of Medicine 2006 354 17 1796 1806 2-s2.0-33646114512 10.1056/NEJMoa054186
35. Srinivas S. K., Edlow A. G., Neff P. M., Sammel M. D., Andrela C. M., Elovitz M. A., Rethinking IUGR in preeclampsia: dependent or independent of maternal hypertension? Journal of Perinatology 2009 29 10 680 684 2-s2.0-70349696285 10.1038/jp.2009.83
36. Conde-Agudelo A., Romero R., Kusanovic J. P., Hassan S. S., Supplementation with vitamins C and e during pregnancy for the prevention of preeclampsia and other adverse maternal and perinatal outcomes: a systematic review and metaanalysis. American Journal of Obstetrics and Gynecology 2011 204 6 503.e1 503.e12 2-s2.0-79958124051 10.1016/j.ajog.2011.02.020
37. Beazley D., Ahokas R., Livingston J., Griggs M., Sibai B. M., Vitamin C and E supplementation in women at high risk for preeclampsia: a double-blind, placebo-controlled trial. American Journal of Obstetrics and Gynecology 2005 192 2 520 521 2-s2.0-13444251471 10.1016/j.ajog.2004.09.005 (Pubitemid 40214989)
38. Rumbold A., Crowther C. A., Vitamin C supplementation in pregnancy. Cochrane Database of Systematic Rreviews 2005 2 CD004072 2-s2.0-21844464894
39. Chappell L. C., Seed P. T., Briley A. L., Kelly F. J., Lee R., Hunt B. J., Parmar K., Bewley S. J., Shennan A. H., Steer P. J., Poston L., Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. The Lancet 1999 354 9181 810 816 2-s2.0-0033523401 10.1016/S0140-6736(99)80010-5 (Pubitemid 29415585)
40. Duthie S. J., Hawdon A., DNA instability (strand breakage, uracil misincorporation, and defective repair) is increased by folic acid depletion in human lymphocytes in vitro. The FASEB Journal 1998 12 14 1491 1497 2-s2.0-0031763502 (Pubitemid 28506718)
41. Cravo M. L., Mason J. B., Dayal Y., Hutchinson M., Smith D., Selhub J., Rosenberg I. H., Folate deficiency enhances the development of colonic neoplasia in dimethylhydrazine-treated rats. Cancer Research 1992 52 18 5002 5006 2-s2.0-0026795472
42. Berry R. J., Li Z., Erickson J. D., Li S., Moore C. A., Wang H., Mulinare J., Zhao P., Wong L. Y. C., Gindler J., Hong S. X., Correa A., Prevention of neural-tube defects with folic acid in China. The New England Journal of Medicine 1999 341 20 1485 1490 2-s2.0-0033547440 10.1056/NEJM199911113412001 (Pubitemid 29526350)
43. Milunsky A., Jick H., Jick S. S., Bruell C. L., MacLaughlin D. S., Rothman K. J., Willett W., Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 1989 262 20 2847 2852 2-s2.0-0024389016 10.1001/jama.262.20.2847 (Pubitemid 20002544)
44. Lillycrop K. A., Phillips E. S., Jackson A. A., Hanson M. A., Burdge G. C., Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. Journal of Nutrition 2005 135 6 1382 1386 2-s2.0-20444411948 (Pubitemid 40799599)
45. Steegers-Theunissen R. P., Obermann-Borst S. A., Kremer D., Lindemans J., Siebel C., Steegers E. A., Slagboom P. E., Heijman B. T., Periconceptional maternal folic acid use of 400 μ g per day is related to increased methylation of the IGF2 gene in the very young child. PLoS ONE 2009 4 11 2-s2.0-70649097099 10.1371/journal.pone.0007845 e7845
46. Honein M. A., Paulozzi L. J., Mathews T. J., Erickson J. D., Wong L. Y. C., Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 2001 285 23 2981 2986 2-s2.0-0035919139 (Pubitemid 32550116)
47. Wen S. W., Zhou J., Yang Q., Fraser W., Olatunbosun O., Walker M., Maternal exposure to folic acid antagonists and placenta-mediated adverse pregnancy outcomes. CMAJ 2008 179 12 1263 1268 2-s2.0-57349193817 10.1503/cmaj.080859
48. Scholl T. O., Hediger M. L., Schall J. I., Khoo C.-S., Fischer R. L., Dietary and serum folate: their influence on the outcome of pregnancy. American Journal of Clinical Nutrition 1996 63 4 520 525 2-s2.0-0029873736 (Pubitemid 26099244)
49. Papadopoulou E., Stratakis N., Roumeliotaki T., Sarri K., Merlo D. F., Kogevinas M., Chatzi L., The effect of high doses of folic acid and iron supplementation in early-to-mid pregnancy on prematurity and fetal growth retardation: the mother-child cohort study in Crete, Greece (Rhea study). European Journal of Nutrition. In press 2-s2.0-84858178631 10.1007/s00394-012- 0339-z
50. Timmermans S., Jaddoe V. W. V., Hofman A., Steegers-Theunissen R. P. M., Steegers E. A. P., Periconception folic acid supplementation, fetal growth and the risks of low birth weight and preterm birth: the Generation R Study. British Journal of Nutrition 2009 102 5 777 785 2-s2.0-73749084803 10.1017/ S0007114509288994
51. Yajnik C. S., Deshpande S. S., Jackson A. A., Refsum H., Rao S., Fisher D. J., Bhat D. S., Naik S. S., Coyaji K. J., Joglekar C. V., Joshi N., Lubree H. G., Deshpande V. U., Rege S. S., Fall C. H. D., Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study. Diabetologia 2008 51 1 29 38 2-s2.0-36649035030 10.1007/s00125-007-0793-y (Pubitemid 350197985)
52. Fletcher J., Gurr A., Fellingham F. R., Prankerd T. A. J., Brant H. A., Menzies D. N., The value of folic acid supplements in pregnancy. Journal of Obstetrics and Gynaecology of the British Commonwealth 1971 78 9 781 785 2-s2.0-0015122152
53. Palma S., Perez-Iglesias R., Prieto D., Pardo R., Llorca J., Delgado-Rodriguez M., Iron but not folic acid supplementation reduces the risk of low birthweight in pregnant women without anaemia: a case-control study. Journal of Epidemiology and Community Health 2008 62 2 120 124 2-s2.0-38849177499 10.1136/jech.2006.052985 (Pubitemid 351196852)
54. Baumslag N., Edelstein T., Metz J., Reduction of incidence of prematurity by folic acid supplementation in pregnancy. BMJ 1970 1 687 16 17 2-s2.0-0014930603
55. Troen A. M., Mitchell B., Sorensen B., Wener M. H., Johnston A., Wood B., Selhub J., McTiernan A., Yasui Y., Oral E., Potter J. D., Ulrichy C. M., Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. Journal of Nutrition 2006 136 1 189 194 2-s2.0-31544483014 (Pubitemid 43156507)
56. Kim Y. I., Will mandatory folic acid fortification prevent or promote cancer? American Journal of Clinical Nutrition 2004 80 5 1123 1128 2-s2.0-16544370325
57. Koblinsky M. A., Beyond maternal mortalitymagnitude, interrelationship, and consequences of women's health, pregnancy-related complications and nutritional status on pregnancy outcomes. International Journal of Gynecology and Obstetrics 1995 48 supplement S21 S32 2-s2.0-0029041617 10.1016/0020- 7292(95)02322-4
58. Ramakrishnan U., Manjrekar R., Rivera J., Gonzáles-Cossío T., Martorell R., Micronutrients and pregnancy outcome: a review of the literature. Nutrition Research 1999 19 1 103 159 2-s2.0-0032961857 10.1016/S0271-5317(98)00178-X (Pubitemid 29019610)
59. Allen L. H., Multiple micronutrients in pregnancy and lactation: an overview. American Journal of Clinical Nutrition 2005 81 5 1206S 1212S 2-s2.0-20544449228 (Pubitemid 41724971)
60. Beard J. L., Effectiveness and strategies of iron supplementation during pregnancy. American Journal of Clinical Nutrition 2000 71 5 1288S 1294S 2-s2.0-0034056566 (Pubitemid 30230531)
61. Jameson S., Zinc status in pregnancy: the effect of zinc therapy on perinatal mortality, prematurity and placental ablation. Annals of the New York Academy of Sciences 1993 678 178 192 2-s2.0-0027241207 10.1111/j.1749-6632.1993. tb26121.x (Pubitemid 23158899)
62. Black R. E., Micronutrients in pregnancy. British Journal of Nutrition 2001 85 supplement 2 S193 S197 2-s2.0-0034956613 (Pubitemid 32586490)
63. Composition of a Multi-Micronutrient Supplement to Be Used in Pilot programmes among pregnant Women in Developing Countries 1999 New York, NY, USA UNICEF/WHO
64. Fawzi W. W., Msamanga G. I., Spiegelman D., Urassa E. J. N., McGrath N., Mwakagile D., Antelman G., Mbise R., Herrera G., Kapiga S., Willett W., Hunter D. J., Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania. The Lancet 1998 351 9114 1477 1482 2-s2.0-0032537366 10.1016/S0140-6736(98)04197-X (Pubitemid 28227039)
65. Osrin D., Vaidya A., Shrestha Y., Baniya R. B., Manandhar D. S., Adhikari R. K., Filteau S., Tomkins A., Costello A. M. D. L., Effects of antenatal multiple micronutrient supplementation on birthweight and gestational duration in Nepal: double-blind, randomised controlled trial. The Lancet 2005 365 9463 955 962 2-s2.0-15844410564 10.1016/S0140-6736(05)71084-9 (Pubitemid 41071429)
66. Vaidya A., Saville N., Shrestha B. P., de L Costello A. M., Manandhar D. S., Osrin D., Effects of antenatal multiple micronutrient supplementation on children's weight and size at 2 years of age in Nepal: follow-up of a double-blind randomised controlled trial. The Lancet 2008 371 9611 492 499 2-s2.0-38849090687 10.1016/S0140-6736(08)60172-5 (Pubitemid 351199865)
67. Ramakrishnan U., González-Cossío T., Neufeld L. M., Rivera J., Martorell R., Multiple micronutrient supplementation during pregnancy does not lead to greater infant birth size than does iron-only supplementation: a randomized controlled trial in a semirural community in Mexico. American Journal of Clinical Nutrition 2003 77 3 720 725 2-s2.0-0037371336 (Pubitemid 36258586)
68. Mathews F., Yudkin P., Neil A., Influence of maternal nutrition on outcome of pregnancy: prospective cohort study. BMJ 1999 319 7206 339 343 2-s2.0-0033533210 (Pubitemid 29364079)
69. Rao S., Yajnik C. S., Kanade A., Fall C. H. D., Margetts B. M., Jackson A. A., Shier R., Joshi S., Rege S., Lubree H., Desai B., Intake of micronutrient-rich foods in rural Indian mothers is associated with the size of their babies at birth: pune maternal nutrition study. Journal of Nutrition 2001 131 4 1217 1224 2-s2.0-0035070666 (Pubitemid 32275104)
70. Huybregts L., Roberfroid D., Lanou H., Menten J., Meda N., Van Camp J., Kolsteren P., Prenatal food supplementation fortified with multiple micronutrients increases birth length: a randomized controlled trial in rural Burkina Faso. American Journal of Clinical Nutrition 2009 90 6 1593 1600 2-s2.0-72749120845 10.3945/ajcn.2009.28253
71. Simopoulos A. P., Importance of the ratio of omega-6/omega-3 essential fatty acids: evolutionary aspects. World Review of Nutrition and Dietetics 2003 92 1 22 2-s2.0-0642311983
72. Simopoulos A. P., Omega-3 fatty acids in health and disease and in growth and development. American Journal of Clinical Nutrition 1991 54 3 438 463 2-s2.0-0026094489 (Pubitemid 21898954)
73. Arterburn L. M., Hall E. B., Oken H., Distribution, interconversion, and dose response of n-3 fatty acids in humans. American Journal of Clinical Nutrition 2006 83 6 1467S 1476S 2-s2.0-33746809138 (Pubitemid 44713087)
74. Endres S., Ghorbani R., Kelley V. E., Georgilis K., Lonnemann G., Van Der Meer J. W. M., Cannon J. G., Rogers T. S., Klempner M. S., Weber P. C., Schaefer E. J., Wolff S. M., Dinarello C. A., The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. The New England Journal of Medicine 1989 320 5 265 271 2-s2.0-0024489402 (Pubitemid 19045549)
75. Kromhout D., Bosschieter E. B., De Lezenne Coulander C., The inverse relation between fish consumption and 20-year mortality from coronary heart disease. The New England Journal of Medicine 1985 312 19 1205 1209 2-s2.0-0021812276 (Pubitemid 15009153)
76. Phillipson B. E., Rothrock D. W., Connor W. E., Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia. The New England Journal of Medicine 1985 312 19 1210 1216 2-s2.0-0021821575 (Pubitemid 15009154)
77. Neuringer M., Connor W. E., Lin D. S., Biochemical and functional effects of prenatal and postnatal ω 3 fatty acid deficiency on retina and brain in rhesus monkeys. Proceedings of the National Academy of Sciences of the United States of America 1986 83 11 4021 4025 2-s2.0-0022445141 (Pubitemid 16062414)
78. Van Eijsden M., Hornstra G., Van Der Wal M. F., Vrijkotte T. G. M., Bonsel G. J., Maternal n-3, n-6, and trans fatty acid profile early in pregnancy and term birth weight: a prospective cohort study. American Journal of Clinical Nutrition 2008 87 4 887 895 2-s2.0-42249093521 (Pubitemid 351549233)
79. Olsen S. F., Sorensen J. D., Secher N. J., Hedegaard M., Henriksen T. B., Hansen H. S., Grant A., Randomised controlled trial of effect of fish-oil supplementation on pregnancy duration. The Lancet 1992 339 8800 1003 1007 2-s2.0-0026521616 10.1016/0140-6736(92)90533-9
80. Olsen S. F., Secher N. J., Tabor A., Weber T., Walker J. J., Gluud C., Randomised clinical trials of fish oil supplementation in high risk pregnancies. BJOG 2000 107 3 382 395 2-s2.0-0034099905 (Pubitemid 30145381)
81. Makrides M., Gibson R. A., McPhee A. J., Yelland L., Quinlivan J., Ryan P., Doyle L. W., Anderson P., Else P. L., Meyer B. J., Colditz P., Pritchard M., Zhou S., Collins C. T., Gulpers Z., McCusker S., Naccarella N., Best K., Loudis H., Anderson A., Griffith E., Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA 2010 304 15 1675 1683 2-s2.0-77958120522 10.1001/jama.2010.1507
82. Muthayya S., Dwarkanath P., Thomas T., Ramprakash S., Mehra R., Mhaskar A., Mhaskar R., Thomas A., Bhat S., Vaz M., Kurpad A. V., The effect of fish and ω -3 LCPUFA intake on low birth weight in Indian pregnant women. European Journal of Clinical Nutrition 2009 63 3 340 346 2-s2.0-62549100943 10.1038/sj.ejcn.1602933
83. Rogers I., Emmett P., Ness A., Golding J., Maternal fish intake in late pregnancy and the frequency of low birth weight and intrauterine growth retardation in a cohort of British infants. Journal of Epidemiology and Community Health 2004 58 6 486 492 2-s2.0-2442683963 10.1136/jech.2003.013565 (Pubitemid 38657303)
84. Onwude J. L., Lilford R. J., Hjartadottir H., Staines A., Tuffnell D., A randomised double blind placebo controlled trial of fish oil in high risk pregnancy. British Journal of Obstetrics and Gynaecology 1995 102 2 95 100 2-s2.0-0028937032
85. Makrides M., Duley L., Olsen S. F., Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction. Cochrane Database of Systematic Reviews 2006 3 CD003402 2-s2.0-33750103624
86. Hilder L., Costeloe K., Thilaganathan B., Prolonged pregnancy: evaluating gestation-specific risks of fetal and infant mortality. British Journal of Obstetrics and Gynaecology 1998 105 2 169 173 2-s2.0-0031930159 (Pubitemid 28096295)
87. Grandjean P., Bjerve K. S., Weihe P., Steuerwald U., Birthweight in a fishing community: significance of essential fatty acids and marine food contaminants. International Journal of Epidemiology 2001 30 6 1272 1278 2-s2.0-0035712908 (Pubitemid 34134272)
88. Oken E., Kleinman K. P., Olsen S. F., Rich-Edwards J. W., Gillman M. W., Associations of seafood and elongated n-3 fatty acid intake with fetal growth and length of gestation: results from a US pregnancy cohort. American Journal of Epidemiology 2004 160 8 774 783 2-s2.0-5444242489 10.1093/aje/kwh282 (Pubitemid 39362215)
89. Signorelli P., Ghidoni R., Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. Journal of Nutritional Biochemistry 2005 16 8 449 466 2-s2.0-22844450866 10.1016/j.jnutbio.2005.01.017 (Pubitemid 41039220)
90. Jeandet P., Bessis R., Sbaghi M., Meunier P., Production of the phytoalexin resveratrol by grapes as a response to botrytis attack under natural conditions. Journal of Phytopathology 1995 143 135 139
91. Rimando A. M., Kalt W., Magee J. B., Dewey J., Ballington J. R., Resveratrol, pterostilbene, and piceatannol in Vaccinium berries. Journal of Agricultural and Food Chemistry 2004 52 15 4713 4719 2-s2.0-3242803476 10.1021/jf040095e
92. Frémont L., Minireview: biological effects of resveratrol. Life Sciences 2000 66 8 663 673 2-s2.0-0034645693 10.1016/S0024-3205(99)00410-5 (Pubitemid 30077860)
93. Rueda-Clausen C. F., Dolinsky V. W., Morton J. S., Proctor S. D., Dyck J. R. B., Davidge S. T., Hypoxia-induced intrauterine growth restriction increases the susceptibility of rats to high-fat diet-induced metabolic syndrome. Diabetes 2011 60 2 507 516 2-s2.0-79551574617 10.2337/db10-1239
94. Bourque S. L., Dolinsky V. W., Dyck J. R. B., Davidge S. T., Maternal resveratrol treatment during pregnancy improves adverse fetal outcomes in a rat model of severe hypoxia. Placenta 2012 33 5 449 452 2-s2.0-84859157597
95. Cudmore M. J., Ramma W., Cai M., Fujisawa T., Ahmad S., Al-Ani B., Ahmed A., Resveratrol inhibits the release of soluble fms-like tyrosine kinase (sFlt-1) from human placenta. American Journal of Obstetrics and Gynecology 2012 206 3 253.e10 253.e15 2-s2.0-84857792906 10.1016/j.ajog.2011.11.010
96. Bergmann A., Ahmad S., Cudmore M., Gruber A. D., Wittschen P., Lindenmaier W., Christofori G., Gross V., Gonzalves A. C. D. C., Gröne H. J., Ahmed A., Weich H. A., Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model. Journal of Cellular and Molecular Medicine 2010 14 6 1857 1867 2-s2.0-77955145573 10.1111/j.1582-4934.2009.00820.x
97. Boocock D. J., Faust G. E. S., Patel K. R., Schinas A. M., Brown V. A., Ducharme M. P., Booth T. D., Crowell J. A., Perloff M., Gescher A. J., Steward W. P., Brenner D. E., Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiology Biomarkers and Prevention 2007 16 6 1246 1252 2-s2.0-34250901592 10.1158/1055-9965.EPI-07-0022 (Pubitemid 46984966)
98. Jang J. Y., Park D., Shin S., Jeon J. H., Choi B. I., Joo S. S., Hwang S. Y., Nahm S. S., Kim Y. B., Antiteratogenic effect of resveratrol in mice exposed in utero to 2,3,7,8-tetrachlorodibenzo-p-dioxin. European Journal of Pharmacology 2008 591 13 280 283 2-s2.0-48949089594 10.1016/j.ejphar.2008.05.033
99. Jahnke G., Marr M., Myers C., Wilson R., Travlos G., Price C., Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats. Toxicological Sciences 1999 50 2 271 279 2-s2.0-0344069780 10.1093/toxsci/50.2.271 (Pubitemid 29407090)
100. Poeggeler B., Saarela S., Reiter R. J., Tan D. X., Chen L. D., Manchester L. C., Barlow-Walden L. R., Melatonina highly potent endogenous radical scavenger and electron donor: new aspects of the oxidation chemistry of this indole accessed in vitro. Annals of the New York Academy of Sciences 1994 738 419 420 2-s2.0-0028618440
101. Reiter R. J., Tan D. X., Poeggeler B., Menendez-Pelaez A., Chen L. D., Saarela S., Melatonin as a free radical scavenger: implications for aging and age-related diseases. Annals of the New York Academy of Sciences 1994 719 1 12 2-s2.0-0028245211 (Pubitemid 24199963)
102. Reiter R. J., Tan D. X., Manchester L. C., Qi W., Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence. Cell Biochemistry and Biophysics 2001 34 2 237 256 2-s2.0-0035754146 10.1385/CBB:34:2:237 (Pubitemid 33615836)
103. Mahal H. S., Sharma H. S., Mukherjee T., Antioxidant properties of melatonin: a pulse radiolysis study. Free Radical Biology and Medicine 1999 26 5-6 557 565 2-s2.0-0033006251 10.1016/S0891-5849(98)00226-3 (Pubitemid 29146258)
104. Tan D. X., Manchester L. C., Reiter R. J., Plummer B. F., Limson J., Weintraub S. T., Qi W., Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin biotransformation. Free Radical Biology and Medicine 2000 29 11 1177 1185 2-s2.0-0034564392 10.1016/S0891- 5849(00)00435-4
105. Richter H. G., Hansell J. A., Raut S., Giussani D. A., Melatonin improves placental efficiency and birth weight and increases the placental expression of antioxidant enzymes in undernourished pregnancy. Journal of Pineal Research 2009 46 4 357 364 2-s2.0-64649086387 10.1111/j.1600-079X.2009.00671.x
106. Thakor A. S., Herrera E. A., Serón-Ferré M., Giussani D. A., Melatonin and vitamin C increase umbilical blood flow via nitric oxide-dependent mechanisms. Journal of Pineal Research 2010 49 4 399 406 2-s2.0-78349249373 10.1111/j.1600-079X.2010.00813.x
107. Lemley C. O., Meyer A. M., Camacho L. E., Neville T. L., Newman D. J., Caton J. S., Vonnahme K. A., Melatonin supplementation alters uteroplacental hemodynamics and fetal development in an ovine model of intrauterine growth restriction. American Journal of Physiology 2012 302 4 R454 R467 2-s2.0-84857600081 10.1152/ajpregu.00407.2011
108. Eng J., Kleinman W. A., Singh L., Singh G., Raufman J. P., Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. The Journal of Biological Chemistry 1992 267 11 7402 7405 2-s2.0-0026648961
109. Chen Y. H., Xu D. X., Wang J. P., Wang H., Wei L. Z., Sun M. F., Wei W., Melatonin protects against lipopolysaccharide-induced intra-uterine fetal death and growth retardation in mice. Journal of Pineal Research 2006 40 1 40 47 2-s2.0-33644899724 10.1111/j.1600-079X.2005.00274.x
110. Drucker D. J., Nauck M. A., The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. The Lancet 2006 368 9548 1696 1705 2-s2.0-33846006173 10.1016/S0140-6736(06)69705-5 (Pubitemid 46048557)
111. Nauck M. A., Kleine N., Orskov C., Holst J. J., Willms B., Creutzfeldt W., Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1(7-36)amide in type 2 (non-insulin-dependent) diabetic patients. Digestion 1993 36 741 744 2-s2.0-0027739847 (Pubitemid 23218642)
112. Nauck M. A., Niedereichholz U., Ettler R., Holst J. J., Orskov C., Ritzel R., Schmiegel W. H., Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. American Journal of Physiology 1997 273 5 E981 E988 2-s2.0-0030667056
113. Drucker D. J., The biology of incretin hormones. Cell Metabolism 2006 3 3 153 165 2-s2.0-33644618433 10.1016/j.cmet.2006.01.004
114. Moller D. E., New drug targets for type 2 diabetes and the metabolic syndrome. Nature 2001 414 6865 821 827 2-s2.0-0035857020 10.1038/414821a (Pubitemid 34000786)
115. Young A. A., Gedulin B. R., Bhavsar S., Bodkin N., Jodka C., Hansen B., Denaro M., Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta). Diabetes 1999 48 5 1026 1034 2-s2.0-0032908654 10.2337/diabetes.48.5.1026 (Pubitemid 29226349)
116. Parkes D. G., Pittner R., Jodka C., Smith P., Young A., Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro. Metabolism 2001 50 5 583 589 2-s2.0-0035340019 10.1053/meta.2001.22519 (Pubitemid 32433049)
117. Goke R., Fehmann H. C., Linn T., Schmidt H., Krause M., Eng J., Goke B., Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin- secreting β -cells. The Journal of Biological Chemistry 1993 268 26 19650 19655 2-s2.0-0027184119 (Pubitemid 23270754)
118. Xu G., Stoffers D. A., Habener J. F., Bonner-Weir S., Exendin-4 stimulates both β -cell replication and neogenesis, resulting in increased β -cell mass and improved glucose tolerance in diabetic rats. Diabetes 1999 48 12 2270 2276 2-s2.0-0033513455 (Pubitemid 30395416)
119. DeFronzo R. A., Ratner R. E., Han J., Kim D. D., Fineman M. S., Baron A. D., Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2. Diabetes Care 2005 28 5 1092 1100 2-s2.0-18144401971 10.2337/diacare.28.5.1092 (Pubitemid 40616618)
120. Kolterman O. G., Buse J. B., Fineman M. S., Gaines E., Heintz S., Bicsak T. A., Taylor K., Kim D., Aisporna M., Wang Y., Baron A. D., Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes. The Journal of Clinical Endocrinology and Metabolism 2003 88 7 3082 3089 2-s2.0-0038497464 10.1210/jc.2002-021545 (Pubitemid 36877476)
121. Simmons R. A., Templeton L. J., Gertz S. J., Intrauterine growth retardation leads to the development of type 2 diabetes in the rat. Diabetes 2001 50 10 2279 2286 2-s2.0-0035489035 (Pubitemid 33641912)
122. Stoffers D. A., Desai B. M., DeLeon D. D., Simmons R. A., Neonatal exendin-4 prevents the development of diabetes in the intrauterine growth retarded rat. Diabetes 2003 52 3 734 740 2-s2.0-0037341252 10.2337/diabetes.52. 3.734 (Pubitemid 36323581)
123. Pinney S. E., Jaeckle Santos L. J., Han Y., Stoffers D. A., Simmons R. A., Exendin-4 increases histone acetylase activity and reverses epigenetic modifications that silence Pdx1 in the intrauterine growth retarded rat. Diabetologia 2011 54 2606 2614 2-s2.0-79960468142 10.1007/s00125-011-2250-1
124. Ham J. N., Crutchlow M. F., Desai B. M., Simmons R. A., Stoffers D. A., Exendin-4 normalizes islet vascularity in intrauterine growth restricted rats: potential role of VEGF. Pediatric Research 2009 66 1 42 46 2-s2.0-70149088456 10.1203/PDR.0b013e3181a282a5
125. Lehmann J. M., Moore L. B., Smith-Oliver T. A., Wilkison W. O., Willson T. M., Kliewer S. A., An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPAR γ). The Journal of Biological Chemistry 1995 270 22 12953 12956 2-s2.0-0029016829 10.1074/jbc.270.22.12953
126. Garg M., Thamotharan M., Pan G., Lee P. W. N., Devaskar S. U., Early exposure of the pregestational intrauterine and postnatal growth-restricted female offspring to a peroxisome proliferator-activated receptor- γ agonist. American Journal of Physiology 2010 298 3 E489 E498 2-s2.0-77349127542 10.1152/ajpendo.00361.2009
127. Vo T., Sohi G., Revesz A., Hardy D. B., Maternal protein restriction results in altered transcriptional and epigenetic regulation of hepatic liver X receptor (LXR) target genes leading to impaired glucose homeostasis in adult rat offspring. Reproductive Sciences 2012 19, article 118A
128. Mitro N., Mak P. A., Vargas L., Godio C., Hampton E., Molteni V., Kreusch A., Saez E., The nuclear receptor LXR is a glucose sensor. Nature 2007 445 7124 219 223 2-s2.0-33846208252 10.1038/nature05449 (Pubitemid 46095727)
129. Repa J. J., Mangelsdorf D. J., The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annual Review of Cell and Developmental Biology 2000 16 459 481 2-s2.0-0034518420 10.1146/annurev.cellbio. 16.1.459 (Pubitemid 32037514)
130. Schultz J. R., Tu H., Luk A., Repa J. J., Medina J. C., Li L., Schwendner S., Wang S., Thoolen M., Mangelsdorf D. J., Lustig K. D., Shan B., Role of LXRs in control of lipogenesis. Genes and Development 2000 14 22 2831 2838 2-s2.0-0034669171 10.1101/gad.850400
131. Laffitte B. A., Chao L. C., Li J., Walczak R., Hummasti S., Joseph S. B., Castrillo A., Wilpitz D. C., Mangelsdorf D. J., Collins J. L., Saez E., Tontonoz P., Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proceedings of the National Academy of Sciences of the United States of America 2003 100 9 5419 5424 2-s2.0-0037965630 10.1073/pnas.0830671100 (Pubitemid 36542720)
132. Sohi G., Revesz A., Arany E., Hardy D. B., The liver X receptor mediates the impaired cholesterol metabolism exhibited in the offspring of maternal protein restricted rats. Reproductive Sciences 2011 18, article F163